Announcements
- Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
- Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
- Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
- Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
- Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
- Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
- Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
- Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
- Harvard Bioscience Announces Third Quarter 2023 Financial Results
- Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
More ▼
Key statistics
On Monday, Harvard Bioscience Inc (HBI:MUN) closed at 3.38, 3.68% above its 52-week low of 3.26, set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.38 |
---|---|
High | 3.38 |
Low | 3.38 |
Bid | 3.48 |
Offer | 3.68 |
Previous close | 3.38 |
Average volume | 21.20 |
---|---|
Shares outstanding | 43.42m |
Free float | 40.26m |
P/E (TTM) | -- |
Market cap | 165.87m USD |
EPS (TTM) | -0.0803 USD |
Data delayed at least 15 minutes, as of Apr 29 2024 07:00 BST.
More ▼